RxDoctor Payments Data

Shirley Santos, MD

General Practice · Kissimmee, FLNPI 1396849931

Payments from drug & device makers

$4,930in general payments, 2019–2025

Across 272 payments — averaging $18.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$1K
  • Novo Nordisk$747
  • AstraZeneca$710
  • Lilly USA, LLC$363
  • Bayer$341
  • Boehringer Ingelheim$337
  • plus $1K from 20 others

What the payments were for

  • Food & beverage$4,930100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,930 in reported general payments places this provider in the 95th percentile of 6,901 general practice providers in Florida.

See all general practice providers in Florida

Medicare billing

Part B allowed, 2024
$4,604
Medicare patients
17
Services billed
56

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin25$27,028
JanuviaSitagliptin Phosphate21$23,314
EliquisApixaban21$20,486
MyrbetriqMirabegron14$11,363
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$6,826
Lantus SolostarInsulin Glargine,hum.Rec.Anlog17$2,895
Atorvastatin Calcium231$2,756
Gabapentin70$1,207
Losartan Potassium133$1,090
Albuterol Sulfate HfaAlbuterol Sulfate29$1,003
Fenofibrate24$642
Lisinopril77$634
Levothyroxine Sodium60$600
Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine15$590
Rosuvastatin Calcium47$562

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$337$27,02825 claims
MerckJanuvia$106$23,31421 claims
PfizerEliquis$198$20,48621 claims
Astellas Pharma US IncMyrbetriq$22$11,36314 claims
GSKTrelegy Ellipta$1,015$6,82611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,901 general practice providers in Florida.

Other general practice in Kissimmee

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →